Lineage Cell Therapeutics Inc Sustainability Reports
A clinical-stage biotechnology company that develops novel cell-based therapies for unmet medical needs.
Sector: Manufacturing
Country: United States
Exchange: NYSE American
ISIN: US53566P1093
2 reports from 2022 to 2023